Brief: Abionyx Pharma: Publication Of Pre-Clinical Data On CER-001

Abionyx Pharma SA

15/12/2020 18:14

Dec 15 (Reuters) - ABIONYX PHARMA SA  ABNX.PA :
    * PUBLICATION OF PRE-CLINICAL DATA IN THE JOURNAL METABOLISM
DEMONSTRATING THAT CER-001 IMPROVES LIPID PROFILE AND KIDNEY
FUNCTION FOR AN ULTRA-RARE KIDNEY DISEASE
    * BENEFICIAL EFFECTS ON LIPID PROFILE AND RENAL FUNCTION
    * REDUCING URINARY ALBUMIN TO CREATININE RATIO AND RESTORING
NESTIN AND NEPHRIN CONTENT IN GLOMERULUS
    * A TREATMENT OPTION FOR PATIENTS WITH ULTRA-RARE KIDNEY
DISEASE

Source text for Eikon:  ID:nNDL9HX2J2 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; 48 58 7696600;))